What are the top competitors of Johnson & Johnson in Healthcare sector?

The top competitors of Johnson & Johnson in the Healthcare sector are: Bristol-Myers Squibb Company (BMY.SW), Biogen Inc. (BIIB.SW), DocMorris AG (ROSE.SW), DocMorris AG (DOCM.SW).

Which has better valuations & earnings, Johnson & Johnson or its competitors?

Johnson & Johnson has a market cap of 0 and a Dividend Yield of 0.52% compared to its competitors.

Which stock is more profitable: Johnson & Johnson or its competitors?

Johnson & Johnson has an EPS of CHFN/A, while BMY.SW has an EPS of CHF2.69. So, Johnson & Johnson is more profitable compared to BMY.SW.

What is Johnson & Johnson stock volatility and risk in terms of investment?

Johnson & Johnson has daily volatility of 0% as compared to its competitor BMY.SW which is 0%. Johnson & Johnson is less volatile as compared to competitors and has low risk.

Is Johnson & Johnson stock profitable?

Johnson & Johnson has a Return on Equity (ROE) of 0.26%. So, Johnson & Johnson is more profitable.

What is Johnson & Johnson stock’s 52 weeks high and low?

Johnson & Johnson stock has a 52-week high of (CHF193.57) and a low of (CHF176.433).

What was the average volume of Johnson & Johnson stock?

The average volume of Johnson & Johnson is (3) in terms of investment.

Johnson & Johnson (JNJ.SW) Competitors

Johnson & Johnson (JNJ.SW) Stock Competitors & Peer Comparison

See (JNJ.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
JNJ.SW	CHF 193.57	+4.86%	0	N/A	N/A	+0.52%
BMY.SW	CHF 42.54	-4.40%	70.7B	15.81	CHF 2.69	+3.50%
BIIB.SW	CHF 147.46	-36.44%	21.6B	21.69	CHF 6.80	N/A
ROSE.SW	CHF 35.02	N/A	404.5M	-2.28	-CHF 15.35	N/A
DOCM.SW	CHF 4.74	-1.25%	230.5M	-1.04	-CHF 4.58	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

JNJ.SW vs BMY.SW Comparison March 2026

JNJ.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, JNJ.SW stands at 0. In comparison, BMY.SW has a market cap of 70.7B. Regarding current trading prices, JNJ.SW is priced at CHF 193.57, while BMY.SW trades at CHF 42.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

JNJ.SW currently has a P/E ratio of N/A, whereas BMY.SW's P/E ratio is 15.81. In terms of profitability, JNJ.SW's ROE is +0.26%, compared to BMY.SW's ROE of +0.37%. Regarding short-term risk, JNJ.SW and BMY.SW have similar daily volatility (0.00).Check BMY.SW's competition here

Johnson & Johnson